Hostname: page-component-8448b6f56d-c47g7 Total loading time: 0 Render date: 2024-04-24T13:23:30.245Z Has data issue: false hasContentIssue false

Antidepressant Drugs and Excessive Weight Gain

Published online by Cambridge University Press:  29 January 2018

Frank Winston
Affiliation:
313 Price Place, Madison, Wisconsin, U.S.A. 53705
Michael L. McCann
Affiliation:
Dept. of Pediatrics, University of Wisconsin School of Medicine, Madison, Wisconsin, U.S.A. 53706
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Copyright
Copyright © Royal College of Psychiatrists, 1972 

References

Arenillas, L. (1964). ‘Amitriptyline and weight gain.’ Lancet, i, 432.CrossRefGoogle Scholar
Axelrod, J., Whitby, L. G., and Herting, G. (1961). ‘Effect of psychotropic drugs on the uptake of H3-norepinephrine by tissues.’ Science, 133, 383.CrossRefGoogle ScholarPubMed
Dally, P. (1967). Chemotherapy of Psychiatric Disorders, pp. 54–6. London: Elek Books.Google Scholar
Gander, D. R. (1965). ‘Treatment of depressive illnesses with combined antidepressants.’ Lancet, ii, 107.CrossRefGoogle Scholar
Hurlimann, A., Thoenen, H., and Haefly, W. (1967). ‘The action of tricyclic antidepressant drugs and related compounds on a-adrenergic receptors and re-uptake of neurally released norepinephrine’, in Proceedings of the First International Symposium on Antidepressant Drugs (eds. Garattini, S., and Dukes, M. N. G.), pp. 168–71. New York: Excerpta Medica Foundation.Google Scholar
Kline, N. S. (1969). Depression: Its Diagnosis and Treatment, pp. 53–4. New York: Bruner/Mazel.Google Scholar
Malaisse, W., Malaisse-Lagae, F., Wright, P. H., and Ashmore, J. (1967). ‘Effects of adrenergic and cholinergic agents upon insulin secretion in vitro.’ Endocrin., 80, 975.Google ScholarPubMed
Malaisse, W., Malaisse-Lagae, F. and Mayhew, D. (1967). ‘A possible role for the adenylcyclase system in insulin secretion.’ J. clin. Invest., 46(11), 1724–33.CrossRefGoogle ScholarPubMed
Pare, C. M. B. (1968). ‘Recent Advances in the Treatment of Depression’, in Recent Developments in Affective Disorders (eds. Coppen, A., and Walk, A.), pp. 137–50. Brit. J. Psychiat. Spec. Publ. No. 2.Google Scholar
Porte, D. Jr. (1967). ‘A receptor mechanism for the inhibition of insulin release by epinephrine in man.’ J. clin. Invest., 1, 8694.CrossRefGoogle Scholar
Porte, D. Jr. (1967). ‘Beta adrenergic stimulation of insulin release in man.’ Diabetes, 16(3), 150–5.CrossRefGoogle ScholarPubMed
Schuckit, M., Robins, E., and Feighner, J. (1971). ‘Tricyclic antidepressants and monoamine oxidase inhibitors.’ Arch. gen. Psychiat., 24, 509.CrossRefGoogle ScholarPubMed
Sigg, E. B. (1959). ‘Pharmacological studies with Tofranil.’ Canad. psychiat. Ass. J., 4, 75.Google Scholar
Turtle, J. R., and Kipnis, D. M. (1967). ‘An adrenergic receptor mechanism for the control of cyclic 3151adenosine monophosphate synthesis in tissues.’ Biochem. Biophys. Res. Comm., 28(5), 797802.CrossRefGoogle ScholarPubMed
Winston, F. (1971). ‘Combined antidepressant therapy.’ Brit. J. Psychiat., 118, 301.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.